- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02228330
Prospective Clinical Trial - Obturator Reflex Predictors and Blockage
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study design: A single center single arm prospective study aiming to estimate the incidence rate of obturator nerve reflex and leg jerking during TURBTs, evaluate the efficacy of obturator nerve block (ONB) in the prevention of inadvertent muscle spasm, and identify predictors for both the jerking reflex and successful nerve block.
Study population: patients who are scheduled for TUR for bladder tumor, as standard care, who are willing and able to participate in the study
Intervention: a uni-lateral ONB (using Lidocaine 2%)
Study outline: Once in the operating room patients will be monitored by continuous electrocardiography, non-invasive arterial blood pressure measurement, and pulse oximetry in the usual manner. They will then undergo general or spinal anesthesia according to their preference and at the discretion of the treating anesthesiologist, without the use of muscle relaxants. As part of the study, a uni-lateral ONB will be performed under ultrasound guidance- using 2% lidocaine for obtaining a short term block, for the duration of the procedure itself. The non-blocked nerve will be used as control. The surgeon will be blinded as to the side in which the ONB has been performed. A catheter will be used to fill the bladder with saline to its full capacity. The inner wall of the bladder will then be stimulated to test for an obturator nerve reflex and leg jerking. Stimulation will be done using a trans-resectoscope and a single-twitch electrical current generated by a neuromuscular monitoring device, as previously described by Mihara et al. Four different bladder volumes will be tested. For each bladder volume, a reflex response on both sides will be documented and graded. The investigators will then proceed with a TUR in the usual manner.
Primary endpoints: frequency of obturator jerk reflex and efficacy of obturator nerve block
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Petach-Tikva, Israel, 4941492
- Rabin Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patient, older than 18 yo, scheduled for TUR for bladder tumor.
- The subject is willing and able to read, understand and sign the study specific informed consent form.
Exclusion Criteria:
- Patients with known coagulopathy, including patients receiving antithrombotic or thrombolytic therapy not in compliance with standard precautions.
- Patients with a known allergy to anesthetics.
- Patients who underwent partial cystectomy.
- Patients with tumors involving bladder diverticula.
- Patients with pre-existing obturator nerve injury or pre-existing neurologic deficits.
- Patients with neuromuscular disease.
- Patients with local infection above planned ONB site.
- Patients in whom the use of muscle relaxants is deemed necessary by the anesthesiologist.
- Patients with inguinal lymphadenopathy.
- Patients unable to sign an informed consent form.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: uni-lateral obturator nerve block
Patients scheduled for TUR for bladder tumor Intervention: uni-lateral obturator nerve block. non-blocked obtorator side of each patient will be used as control |
a uni-lateral obturator nerve block will be performed under ultrasound guidance- using 2% lidocaine for obtaining a short term block.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
efficacy of obturator nerve block in preventing inadvertent obturator jerk
Time Frame: intraoperative
|
percentage of subjects for which the obtorator nerve block prevnted inadvertent obturator jerk
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
incidence rate of obturator nerve jerk reflex
Time Frame: end of study (one year)
|
frequency of obturator nerve jerk reflex
|
end of study (one year)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0063-14-RMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Neoplasm of Urinary Bladder
-
Sahlgrenska University Hospital, SwedenThe Swedish Research Council; Sjöbergstiftelsen; VGregionRecruitingGynecologic Cancer | Malignant Neoplasm | Malignant Neoplasm of Large Intestine | Malignant Neoplasm of Colon | Malignant Neoplasm of Prostate | Malignant Neoplasm of Rectum | Malignant Neoplasm of Anus | Malignant Neoplasm of Urinary Bladder | Malignant Neoplasm of Cervix | Malignant Neoplasm of OvarySweden
-
Tata Memorial HospitalCompletedPancreatic Neoplasms Malignant | Malignant Neoplasm of Gall Bladder Non-resectableIndia
-
Medical Enterprises Ltd.TerminatedUrinary Bladder Cancer | Bladder Cancer | Malignant Tumor of Urinary Bladder | Bladder Neoplasm | Cancer of Bladder | Carcinoma in Situ of Bladder | Bladder Tumors | Cancer of the Bladder | Neoplasms, Bladder | Papillary Carcinoma of Bladder (Diagnosis) | BCG-Unresponsive Bladder CancerUnited States
-
Case Comprehensive Cancer CenterNot yet recruitingMuscle Invasive Bladder Carcinoma | Malignant Neoplasm of BladderUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen...RecruitingStage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Bladder Adenocarcinoma | Bladder Squamous Cell Carcinoma | Metastatic Bladder Carcinoma | Urachal Adenocarcinoma | Locally Advanced Bladder Carcinoma | Malignant Renal Pelvis Neoplasm | Malignant Ureter Neoplasm | Malignant Urethral Neoplasm and other conditionsUnited States
-
NanOlogy, LLCUS Biotest, Inc.CompletedUrologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Cancer | Bladder Cancer | Urothelial Carcinoma | Urologic Cancer | Urinary Bladder Neoplasm | Cancer of the Bladder | Malignant Tumor of the Urinary BladderUnited States
-
Tata Medical CenterCompletedMalignant Neoplasm of Oropharynx Stage III | Malignant Neoplasm of Larynx Stage III | Malignant Neoplasm of Hypopharynx Stage III | Malignant Neoplasm of Oropharynx Stage IVa | Malignant Neoplasm of Oropharynx Stage IVb | Malignant Neoplasm of Larynx Stage IV | Malignant Neoplasm of Hypopharynx... and other conditionsIndia
-
Daniel Stephan EngelerCompletedNeoplasm of Lateral Wall of Urinary BladderSwitzerland
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompletedBladder Cancer | Malignant Neoplasms of Urinary TractUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedLow Anterior Resection Syndrome | Malignant Uterine Neoplasm | Rectal Carcinoma | Malignant Ovarian Neoplasm | Malignant Pelvic Neoplasm | Malignant Anal Neoplasm | Malignant Bladder Neoplasm | Malignant Cervical Neoplasm | Malignant Prostate Neoplasm | Malignant Vaginal Neoplasm | Malignant Vulvar NeoplasmUnited States
Clinical Trials on obturator nerve block
-
Yonsei UniversityCompleted
-
Milton S. Hershey Medical CenterCompleted
-
Lawson Health Research InstituteCompletedAnterior Cruciate Ligament ReconstructionCanada
-
Clinique Medipole GaronneCompletedPrimary Total Knee ArthroplastyFrance
-
Ankara Training and Research HospitalCompletedBladder Cancer Stage 0 | Bladder Cancer Stage ITurkey
-
Ankara City Hospital BilkentNot yet recruitingObturator Nerve Block | Ultrasound Guided Nerve Block | Complications NeurologicalTurkey
-
Muğla Sıtkı Koçman UniversityRecruitingBleeding | Bladder Tumor | Succesful Obturator Nerve BlockTurkey
-
Medical University of GrazCompleted
-
Larissa University HospitalCompletedSurgery | Anterior Cruciate LigamentGreece
-
Bispebjerg HospitalCompleted